Role of proliferative markers in breast lesions

被引:1
|
作者
Manna, Asim Kumar [1 ]
Pathak, Swapan [1 ]
Sarkar, Diptendra Kumar [2 ]
机构
[1] IPGME&R, Dept Pathol, Kolkata, India
[2] IPGME&R, Dept Surg, Kolkata, India
关键词
Breast lesions; Proliferative markers; DUCTAL CARCINOMA;
D O I
10.1007/s12262-010-0010-y
中图分类号
R61 [外科手术学];
学科分类号
摘要
Carcinoma of breast is a leading cause of death in women throughout the world. Difficulty in diagnosis occurs in routine Hematoxylin and Eosin (H&E) stained sections to differentiate premalignant lesions like epitheliosis and malignant lesions like carcinoma in situ which may affect prognosis. Our study was done to assess the role of proliferative markers in this field. In this study, total 66 cases of different breast lesions were studied by H&E stained sections as well as proliferative markers like silver staining nucleolar organizer region (AgNOR) and proliferating cell nuclear antigen (PCNA). Statistically significant differences found in expression of proliferative markers between most of them. Study of proliferative markers help in the proper diagnosis of different breast lesions which lies in the grey zone on routine histopathology.
引用
收藏
页码:57 / 61
页数:5
相关论文
共 50 条
  • [21] The prognostic value of apoptotic and proliferative markers in breast cancer
    Engels, Charla C.
    Ruberta, Francesca
    de Kruijf, Esther M.
    van Pelt, Gabi W.
    Smit, Vincent T. H. B. M.
    Liefers, Gerrit Jan
    Matsushima, Tomoko
    Shibayama, Masaki
    Ishihara, Hideki
    van de Velde, Cornelis J. H.
    Kuppen, Peter J. K.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 142 (02) : 323 - 339
  • [22] Immunohistochemical markers in papillary lesions of the breast
    Troxell, ML
    Masek, M
    Sibley, RK
    LABORATORY INVESTIGATION, 2002, 82 (01) : 54A - 54A
  • [23] Proliferation markers in preinvasive breast lesions
    Shoker B.
    Breast Cancer Research, 1 (1)
  • [24] The prognostic value of apoptotic and proliferative markers in breast cancer
    Charla C. Engels
    Francesca Ruberta
    Esther M. de Kruijf
    Gabi W. van Pelt
    Vincent T. H. B. M. Smit
    Gerrit Jan Liefers
    Tomoko Matsushima
    Masaki Shibayama
    Hideki Ishihara
    Cornelis J. H. van de Velde
    Peter J. K. Kuppen
    Breast Cancer Research and Treatment, 2013, 142 : 323 - 339
  • [25] Cytogenetic changes in benign proliferative and nonproliferative lesions of the breast
    Lundin, CP
    Mertens, F
    Rizou, H
    Idvall, I
    Georgiou, G
    Ingvar, C
    Pandis, N
    CANCER GENETICS AND CYTOGENETICS, 1998, 107 (02) : 118 - 120
  • [26] Occult carcinoma and proliferative epithelial lesions in contralateral breast
    Alvarenga, M
    Brenelli, HB
    Pinotti, JA
    10TH INTERNATIONAL CONGRESS ON SENOLOGY - BREAST DISEASES OF THE SENOLOGIC INTERNATIONAL SOCIETY, 1998, : 639 - 643
  • [27] Automated Classification of Benign and Malignant Proliferative Breast Lesions
    Evani Radiya-Dixit
    David Zhu
    Andrew H. Beck
    Scientific Reports, 7
  • [28] Clonal evolution of atypical proliferative lesions into breast cancers
    Nishimura, Tomomi
    Yoshida, Kenichi
    Kawata, Yukiko
    Shiozawa, Yusuke
    Kataoka, Tatsuki R.
    Sakurai, Takaki
    Shiraishi, Yuichi
    Chiba, Kenichi
    Haga, Hironori
    Miyano, Satoru
    Toi, Masakazu
    Ogawa, Seishi
    CANCER SCIENCE, 2018, 109 : 663 - 663
  • [29] The Incidence of Proliferative Lesions and Breast Cancer in Reduction Mammaplasty
    Ouyang, Yiye
    Li, Chengcheng
    Du, Xingyi
    Liu, Chunjun
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2020, 145 (02) : 444E - 445E
  • [30] Clonal evolution of proliferative lesions into breast cancers.
    Nishimura, Tomomi
    Kakiuchi, Nobuyuki
    Yoshida, Kenichi
    Takeuchi, Yasuhide
    Maeda, Hirona
    Shiozawa, Yusuke
    Nakagawa, Masahiro M.
    Ochi, Yotaro
    Kawata, Yukiko
    Aoki, Kosuke
    Hirata, Masahiro
    Kataoka, Tatsuki R.
    Sakurai, Takaki
    Baba, Satoko
    Shiraishi, Yuichi
    Chiba, Kenichi
    Takeuchi, Kengo
    Haga, Hironori
    Miyano, Satoru
    Toi, Masakazu
    Ogawa, Seishi
    CANCER RESEARCH, 2021, 81 (13)